Display Settings:

Format

Send to:

Choose Destination
    J Am Chem Soc. 2009 Apr 15;131(14):5153-62.

    Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.

    Source

    Department of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, Illinois 61801, USA.

    Abstract

    Considerable effort has focused on the development of selective protein farnesyl transferase (FTase) and protein geranylgeranyl transferase (GGTase) inhibitors as cancer chemotherapeutics. Here, we report a new strategy for anticancer therapeutic agents involving inhibition of farnesyl diphosphate synthase (FPPS) and geranylgeranyl diphosphate synthase (GGPPS), the two enzymes upstream of FTase and GGTase, by lipophilic bisphosphonates. Due to dual site targeting and decreased polarity, the compounds have activities far greater than do current bisphosphonate drugs in inhibiting tumor cell growth and invasiveness, both in vitro and in vivo. We explore how these compounds inhibit cell growth and how cell activity can be predicted based on enzyme inhibition data, and using X-ray diffraction, solid state NMR, and isothermal titration calorimetry, we show how these compounds bind to FPPS and/or GGPPS.

    PMID:
    19309137
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2753403
    Free PMC Article

    Images from this publication.See all images (8) Free text

    Figure 2
    Figure 4
    Figure 6
    Figure 8
    Figure 1
    Figure 3
    Figure 5
    Figure 7

      Supplemental Content

      Icon for American Chemical Society Icon for PubMed Central

      Save items

      loading

      Structures reported by this article

      See all 8 structures...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk